BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37548745)

  • 1. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
    Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
    Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
    Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
    Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
    Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
    Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
    Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
    Nemeth Z; Farkas N; Farkas B
    Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female Sexual Functioning in Women With a Symptomatic Pelvic Organ Prolapse; A Multicenter Prospective Comparative Study Between Pessary and Surgery.
    van der Vaart LR; Vollebregt A; Pruijssers B; Milani AL; Lagro-Janssen AL; Roovers JWR; van der Vaart CH
    J Sex Med; 2022 Feb; 19(2):270-279. PubMed ID: 34969614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pessary fitting for pelvic organ prolapse: parameters associated with specific reasons for failure.
    Manzini C; van der Vaart CH; van den Noort F; Grob ATM; Withagen MIJ
    Int Urogynecol J; 2022 Jul; 33(7):2037-2046. PubMed ID: 35066658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
    Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
    Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
    Chan MC; Hyakutake M; Yaskina M; Schulz JA
    J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal pessaries for pelvic organ prolapse and urinary incontinence: a multiprofessional survey of practice.
    Bugge C; Hagen S; Thakar R
    Int Urogynecol J; 2013 Jun; 24(6):1017-24. PubMed ID: 23179500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing long-term pessary use.
    Friedman S; Sandhu KS; Wang C; Mikhail MS; Banks E
    Int Urogynecol J; 2010 Jun; 21(6):673-8. PubMed ID: 20062974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of successful ring pessary use in women with pelvic organ prolapse.
    Turel Fatakia F; Pixton S; Caudwell Hall J; Dietz HP
    Aust N Z J Obstet Gynaecol; 2020 Aug; 60(4):579-584. PubMed ID: 32297314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
    Ding J; Song XC; Deng M; Zhu L
    Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of ring pessary with support for advanced pelvic organ prolapse.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.